Vaxcyte, Inc. (PCVX) Tops Q3 EPS by 27c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($0.83), $0.27 better than the analyst estimate of ($1.10).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Raymond James on Whirlpool Corporation (WHR): 'July Major Appliance Industrial Production Remained Weak'
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Increasing unusual option volume: REAL AMLX ALHC OPRA MSGS AS BNTX CYPH PGEN LYTE CIA AZ PSNL